Vimarsana
Biggest News Aggregation in the World

Page 7 - Active Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Active Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Active Biotech Today - Breaking & Trending Today

Investegate |Active Biotech Announcements | Active Biotech: Active Biotech's nomination committee appointed - Vimarsana News

Investegate |Active Biotech Announcements | Active Biotech: Active Biotech's nomination committee appointed

Investegate announcements from Active Biotech, Active Biotech's nomination committee appointed

Active Biotech's nomination committee appointed - Vimarsana News

Active Biotech's nomination committee appointed

In accordance with a decision made by the Annual General Meeting held on May 19, 2021, the Nomination Committee shall comprise the representatives for the three largest shareholders by votes, as per end

Data on naptumomab estafenatox enhancing CAR-T cells potency presented by Active Biotech's partner NeoTX at SITC 2021 - Vimarsana News

Data on naptumomab estafenatox enhancing CAR-T cells potency presented by Active Biotech's partner NeoTX at SITC 2021

Lund, Sweden - November 30, 2021 - Active Biotech and its partner NeoTX announced that the preclinical data on naptumomab enhancing the potency of CAR-T cells was presented on Nov 12th at the Society for

Active Biotech Interim report January - September 2021 - Vimarsana News

Active Biotech Interim report January - September 2021

"We have seen the first encouraging results from the ongoing tasquinimod trial in multiple myeloma and started a new combination study with naptumomab and docetaxel in lung cancer" THIRD QUARTER

Related Topics:
Hans KolamActive Biotech
Active Biotech: New preclinical data on tasquinimod will be presented at the annual meeting of American Society of Hematology (ASH) - Vimarsana News

Active Biotech: New preclinical data on tasquinimod will be presented at the annual meeting of American Society of Hematology (ASH)

Lund, November 4, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that two abstracts with new preclinical data on tasquinimod, a small molecule immunomodulator, have been accepted for presentation